Ausgabe 1/2012
Inhalt (41 Artikel)
The role of caveolin-1 in human breast cancer
Neill Patani, Lesley-Ann Martin, Jorge S. Reis-Filho, Mitch Dowsett
Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women
Fangyi Gu, Peter Kraft, Megan Rice, Karin B. Michels
The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk
Ke-Da Yu, Ao-Xiang Chen, Chen Yang, Lei Fan, A-Ji Huang, Zhi-Ming Shao
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer
Carina Strand, Cecilia Ahlin, Pär-Ola Bendahl, Marie-Louise Fjällskog, Ingrid Hedenfalk, Per Malmström, Mårten Fernö
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers
T. R. Lester, K. K. Hunt, K. M. Nayeemuddin, R. L. Bassett Jr, A. M. Gonzalez-Angulo, B. W. Feig, L. Huo, L. L. Rourke, W. G. Davis, V. Valero, M. Z. Gilcrease
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells
Aurélie Courtin, Laudine Communal, Myriam Vilasco, Daniela Cimino, Najat Mourra, Michele de Bortoli, Daniela Taverna, Anne-Marie Faussat, Marc Chaouat, Patricia Forgez, Anne Gompel
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
Juan Du, Lin Li, Zhouluo Ou, Chenfei Kong, Yu Zhang, Zhixiong Dong, Shan Zhu, Hao Jiang, Zhimin Shao, Baiqu Huang, Jun Lu
Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint
Melanie M. Badtke, Purevsuren Jambal, Wendy W. Dye, Monique A. Spillman, Miriam D. Post, Kathryn B. Horwitz, Britta M. Jacobsen
Cancer predisposing BARD1 mutations in breast–ovarian cancer families
Magdalena Ratajska, Ewelina Antoszewska, Anna Piskorz, Izabela Brozek, Åke Borg, Hanna Kusmierek, Wojciech Biernat, Janusz Limon
The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial
Virginia P. Henderson, Lynn Clemow, Ann O. Massion, Thomas G. Hurley, Susan Druker, James R. Hébert
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
Devika Gajria, Joseph Gonzalez, Kimberly Feigin, Sujata Patil, Carol Chen, Maria Theodoulou, Pamela Drullinsky, Gabriella D’Andrea, Diana Lake, Larry Norton, Clifford A. Hudis, Tiffany A. Traina
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B. Koolen, Marie-Jeanne T. F. D. Vrancken Peeters, Tjeerd S. Aukema, Wouter V. Vogel, Hester S. A. Oldenburg, Jos A. van der Hage, Cornelis A. Hoefnagel, Marcel P. M. Stokkel, Claudette E. Loo, Sjoerd Rodenhuis, Emiel J. Th. Rutgers, Renato A. Valdés Olmos
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer
Alain Lortholary, Anne-Claire Hardy-Bessard, Thomas Bachelot, Gaëtan de Rauglaudre, Jérôme Alexandre, Hugues Bourgeois, Dominique Jaubert, Désiré Paraiso, Rémy Largillier
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients
Kazuma Kiyotani, Taisei Mushiroda, Chiyo K. Imamura, Yusuke Tanigawara, Naoya Hosono, Michiaki Kubo, Mitsunori Sasa, Yusuke Nakamura, Hitoshi Zembutsu
A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema
Sheila H. Ridner, Barbara Murphy, Jie Deng, Nancy Kidd, Emily Galford, Candace Bonner, Stewart M. Bond, Mary S. Dietrich
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer
Rulla M. Tamimi, Graham A. Colditz, Aditi Hazra, Heather J. Baer, Susan E. Hankinson, Bernard Rosner, Jonathan Marotti, James L. Connolly, Stuart J. Schnitt, Laura C. Collins
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors
Madiha F. Abdel-Maksoud, Betsy C. Risendal, Marty L. Slattery, Anna R. Giuliano, Kathy B. Baumgartner, Tim E. Byers
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study
Carolina Ellberg, Helena Jernström, Håkan Olsson
Lifecourse predictors of mammographic density: the Newcastle Thousand Families cohort Study
Mark S. Pearce, Peter W. G. Tennant, Kay D. Mann, Tessa M. Pollard, Lesley McLean, Brenda Kaye, Louise Parker
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients
Yoon Hee Cho, Jing Shen, Marilie D. Gammon, Yu-Jing Zhang, Qiao Wang, Karina Gonzalez, Xinran Xu, Patrick T. Bradshaw, Susan L. Teitelbaum, Gail Garbowski, Hanina Hibshoosh, Alfred I. Neugut, Jia Chen, Regina M. Santella
Predictors of timing of adjuvant chemotherapy in older women with hormone receptor–negative, stages II–III breast cancer
Stephanie B. Wheeler, William R. Carpenter, Jeffrey Peppercorn, Anna P. Schenck, Morris Weinberger, Andrea K. Biddle
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients
Jae Myoung Noh, Doo Ho Choi, Seok Jin Nam, Jeong Eon Lee, Jong Won Kim, Sung-Won Kim, Eunyoung Kang, Min Hyuk Lee, Sei Hyun Ahn, Ku Sang Kim, Sue K. Park, Bruce G. Haffty
Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer
Tove F. Tvedskov, Maj-Britt Jensen, Niels Kroman, Eva Balslev
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999–2006
Nalini Sathiakumar, Elizabeth Delzell, Michael A. Morrisey, Carla Falkson, Mellissa Yong, Victoria Chia, Justin Blackburn, Tarun Arora, Ilene Brill, Meredith L. Kilgore
Carotenoids and breast cancer risk: a meta-analysis and meta-regression
Fulan Hu, Baina Wang Yi, Wencui Zhang, Jing Liang, Chunqing Lin, Dandan Li, Fan Wang, Da Pang, Yashuang Zhao
The vitamin D pathway and mammographic breast density among postmenopausal women
Brian L. Sprague, Amy Trentham-Dietz, Ronald E. Gangnon, Diana S. M. Buist, Elizabeth S. Burnside, Erin J. Aiello Bowles, Frank Z. Stanczyk, Gale S. Sisney, Halcyon G. Skinner
Tissue composition of mammographically dense and non-dense breast tissue
Karthik Ghosh, Kathleen R. Brandt, Carol Reynolds, Christopher G. Scott, V. S. Pankratz, Darren L. Riehle, Wilma L. Lingle, Tonye Odogwu, Derek C. Radisky, Daniel W. Visscher, James N. Ingle, Lynn C. Hartmann, Celine M. Vachon
A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms
Kathy J. Helzlsouer, Lisa Gallicchio, Ryan MacDonald, Bethany Wood, Errol Rushovich
Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women
Roni T. Falk, Elisabet Gentzschein, Frank Z. Stanczyk, Montserrat Garcia-Closas, Jonine D. Figueroa, Olga B. Ioffe, Jolanta Lissowska, Louise A. Brinton, Mark E. Sherman
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
Jacquie Chirgwin, Zhuoxin Sun, Ian Smith, Karen N. Price, Beat Thürlimann, Bent Ejlertsen, Hervé Bonnefoi, Meredith M. Regan, Aron Goldhirsch, Alan S. Coates
Non-existence of caveolin-1 gene mutations in human breast cancer
Neill Patani, Maryou B. Lambros, Rachael Natrajan, Konstantin J. Dedes, Felipe C. Geyer, Eric Ward, Lesley-Ann Martin, Mitch Dowsett, Jorge S. Reis-Filho
Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival
Verena Varadi, Melanie Bevier, Ewa Grzybowska, Robert Johansson, Kerstin Enquist-Olsson, Roger Henriksson, Dorota Butkiewicz, Jolanta Pamula-Pilat, Karolina Tecza, Kari Hemminki, Per Lenner, Asta Försti
Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models
Elizabeth Iorns, Jennifer Clarke, Toby Ward, Sonja Dean, Marc Lippman
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor
Sarah V. Colonna, L. Douglas Case, Julia A. Lawrence
The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent
Stephanie Cote, Suzanna L. Arcand, Robert Royer, Serge Nolet, Anne-Marie Mes-Masson, Parviz Ghadirian, William D. Foulkes, Marc Tischkowitz, Steven A. Narod, Diane Provencher, Patricia N. Tonin
Erratum to: The BRCA2 c.9004G>A (E3002K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent
Stephanie Cote, Suzanna L. Arcand, Robert Royer, Serge Nolet, Anne-Marie Mes-Masson, Parviz Ghadirian, William D. Foulkes, Marc Tischkowitz, Steven A. Narod, Diane Provencher, Patricia N. Tonin
Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy
Bethany Wilson, Christy Sapp, Ghadeer Abdeen, Atheel Kamona, Suleiman Massarweh
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
Christina Justenhoven, Ofure Obazee, Stefan Winter, Fergus J. Couch, Janet E. Olson, Per Hall, Ulf Hannelius, Jingmei Li, Keith Humphreys, Gianluca Severi, Graham Giles, Melissa Southey, Laura Baglietto, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Ute Hamann, Christian Baisch, Volker Harth, Sylvia Rabstein, Anne Lotz, Beate Pesch, Thomas Brüning, Yon-Dschun Ko, Hiltrud Brauch
Regarding “Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients”
Hiu-Fung Yuen, Shu-Dong Zhang, Ashley San-Yu Wong, Cian M. McCrudden, Yu-Han Huang, Kelvin Yuen-Kwong Chan, Mohamed El-Tanani, Ui-Soon Khoo
Erratum to: HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies
Su Lu, Zhanwei Wang, Hong Liu, Xishan Hao
Erratum to: Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects
Su Lu, Zhanwei Wang, Dan Cui, Hong Liu, Xishan Hao